SCHEMBL7563241

SCHEMBL7563241

COC(=O)c1ccc(NC2CCCC2)c(C)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.57
SMN1; SMN2 Q16637 4/20 0.57
HDAC8 Q9BY41 1/20 0.53
ALDH1A1 P00352 6/20 0.52
LMNA P02545 2/20 0.52
MAPT P10636 1/20 0.52
CRHBP P24387 1/20 0.52
CRHR2 Q13324 1/20 0.52
YAP1 P46937 1/20 0.51
NPC1 O15118 1/20 0.48
EPHX2 P34913 1/20 0.48
HCAR3 P49019 2/20 0.47
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
MEN1 O00255 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
KMT2A Q03164 1/20 0.46
NPSR1 Q6W5P4 2/20 0.45
ATM Q13315 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16579935 0.99 ALOX15 (0.60) ALOX15SMN1; SMN2HDAC8ALDH1A1LMNA
SCHEMBL28164487 0.94 SMN1; SMN2 (0.53) ALOX15SMN1; SMN2HDAC8ALDH1A1LMNA
SCHEMBL27218058 0.88 ALOX15 (0.56) ALOX15SMN1; SMN2HDAC8ALDH1A1LMNA
SCHEMBL19245015 0.87 ALOX15 (0.75) ALOX15SMN1; SMN2HDAC8ALDH1A1LMNA
SCHEMBL19245014 0.86 ALOX15 (0.77) ALOX15SMN1; SMN2HDAC8ALDH1A1LMNA
SCHEMBL16579940 0.85 ALOX15 (0.55) ALOX15SMN1; SMN2HDAC8ALDH1A1LMNA
SCHEMBL6556860 0.85 HCAR3 (0.63) ALOX15SMN1; SMN2HDAC8ALDH1A1LMNA
SCHEMBL19245016 0.85 ALOX15 (0.71) ALOX15SMN1; SMN2HDAC8ALDH1A1LMNA
SCHEMBL24100991 0.84 ALOX15 (0.56) ALOX15SMN1; SMN2HDAC8ALDH1A1LMNA
SCHEMBL3742643 0.84 ALOX15 (0.53) ALOX15SMN1; SMN2HDAC8ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020151534-A1 Antithrombotic compounds BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020151534-A1 Antithrombotic compounds SERPINC1, PF4, F2 ALOX15 169/4885SMN1; SMN2 1107/4885HDAC8 1662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.